India Pharmaceutical Logistics Market Forecast 2024-2032

The India pharmaceutical logistics market is predicted to develop at a CAGR of 9.00% during the forecast period 2024-2032. Diverse enablers foster market growth, like the rising need for temperature-controlled solutions in pharmaceuticals, the expansion of ocean freight services in the pharmaceutical industry, the rise in consumer preference for over-the-counter medicines, and the surge in pharmaceutical logistics during the India COVID-19 pandemic.

MARKET INSIGHTS

The India pharmaceutical logistics market is a strong evolving sector that plays a vital role in ensuring the timely and efficient distribution of pharmaceutical products across the country. With India's pharmaceutical industry experiencing robust growth and diversification, driven by factors such as increasing healthcare spending, a growing population, and rising demand for quality healthcare products, the need for reliable and effective logistics solutions has become paramount.

Pharmaceutical logistics in India includes a range of services including transportation, warehousing, inventory management, cold chain logistics for temperature-sensitive products, and regulatory compliance. The market is characterized by a network of logistics providers, including third-party logistics (3PL) companies, pharmaceutical distributors, freight forwarders, and specialized cold-chain logistics providers, all working together to meet the unique requirements of the pharmaceutical supply chain.

The implementation of Good Distribution Practices (GDP) and stringent regulatory standards have further pushed the demand for advanced pharmaceutical logistics solutions in India. Market players are investing in technology-driven solutions such as track-and-trace systems, temperature monitoring devices, and digital platforms to ensure product integrity, regulatory compliance, and supply chain visibility. As India's pharmaceutical domain continues to expand and innovate, the pharmaceutical logistics market is poised for sustained growth, driven by the increasing complexity and sophistication of supply chain operations in the healthcare sector.

COMPETITIVE INSIGHTS

Some of the major companies in the India pharmaceutical logistics market include Agility Logistics, Cardinal Health, Cencora (AmerisourceBergen), CEVA Logistics, etc.

Our report offerings include:

Explore key findings of the overall market
Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
Market Segmentation caters to a thorough assessment of key segments with their market estimations
Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
The competitive landscape is the theoretical explanation of the key companies based on factors such as market share.
Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 85204

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.6. MAJOR MARKET FINDINGS
- 2.6.1. BRANDED DRUGS ARE THE MOST COMMONLY USED PRODUCTS IN THE PHARMACEUTICAL LOGISTICS MARKET
- 2.6.2. COMMUNICABLE DISEASES HOLD THE LARGEST MARKET SHARE IN THE THERAPY AREA
- 2.6.3. COLD CHAIN LOGISTICS IS THE FASTEST-GROWING TYPE WITHIN THE PHARMACEUTICAL LOGISTICS MARKET
- 2.6.4. MONITORING OF PHARMACEUTICAL LOGISTICS OPERATIONS IS INCREASINGLY BECOMING A FOCUS AREA

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING NEED FOR TEMPERATURE-CONTROLLED SOLUTIONS IN PHARMACEUTICALS
- 3.1.2. EXPANSION OF OCEAN FREIGHT SERVICES IN PHARMACEUTICAL INDUSTRY
- 3.1.3. RISE IN CONSUMER PREFERENCE FOR OVER-THE-COUNTER MEDICINES
- 3.1.4. SURGE IN PHARMACEUTICAL LOGISTICS DURING THE INDIA COVID-19 PANDEMIC
3.2. KEY RESTRAINTS
- 3.2.1. RIGOROUS REGULATORY REQUIREMENTS IN PHARMACEUTICAL LOGISTICS
- 3.2.2. ENSURING REAL-TIME TRANSPARENCY AND RELIABILITY IN PHARMACEUTICAL LOGISTICS

4. KEY ANALYTICS

4.1. KEY MARKET TRENDS
- 4.1.1. SURGE IN DEMAND FOR CELL & GENE THERAPY LOGISTICS
- 4.1.2. REVOLUTIONIZING PHARMACEUTICAL LOGISTICS THROUGH DIGITAL TRANSFORMATION
- 4.1.3. INCREASING CLINICAL TRIALS LOGISTICS DEMANDS
4.2. PORTER'S FIVE FORCES ANALYSIS
- 4.2.1. BUYERS POWER
- 4.2.2. SUPPLIERS POWER
- 4.2.3. SUBSTITUTION
- 4.2.4. NEW ENTRANTS
- 4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
- 4.3.1. GROWTH PROSPECT MAPPING FOR INDIA
4.4. MARKET CONCENTRATION ANALYSIS
4.5. VALUE CHAIN ANALYSIS
- 4.5.1. MANUFACTURING
- 4.5.2. STORAGE
- 4.5.3. TRANSPORTATION
- 4.5.4. DISTRIBUTION
- 4.5.5. MONITORING COMPONENTS
- 4.5.6. CONSUMPTION
4.6. KEY BUYING CRITERIA
- 4.6.1. TYPE OF LOGISTICS
- 4.6.2. SERVICES OFFERED
- 4.6.3. MODE OF TRANSPORTATION
- 4.6.4. APPLICATION
- 4.6.5. REGULATORY COMPLIANCE
- 4.6.6. TECHNOLOGICAL CAPABILITIES
- 4.6.7. COST
- 4.6.8. RELIABILITY
- 4.6.9. AGILITY

5. MARKET BY PRODUCT

5.1. BRANDED DRUGS
- 5.1.1. MARKET FORECAST FIGURE
- 5.1.2. SEGMENT ANALYSIS
5.2. GENERIC DRUGS
- 5.2.1. MARKET FORECAST FIGURE
- 5.2.2. SEGMENT ANALYSIS
5.3. OTC
- 5.3.1. MARKET FORECAST FIGURE
- 5.3.2. SEGMENT ANALYSIS

6. MARKET BY THERAPY AREA

6.1. COMMUNICABLE DISEASES
- 6.1.1. MARKET FORECAST FIGURE
- 6.1.2. SEGMENT ANALYSIS
6.2. ONCOLOGY
- 6.2.1. MARKET FORECAST FIGURE
- 6.2.2. SEGMENT ANALYSIS
6.3. DIABETES
- 6.3.1. MARKET FORECAST FIGURE
- 6.3.2. SEGMENT ANALYSIS
6.4. CARDIOVASCULAR DISEASES
- 6.4.1. MARKET FORECAST FIGURE
- 6.4.2. SEGMENT ANALYSIS
6.5. AUTOIMMUNE DISEASES
- 6.5.1. MARKET FORECAST FIGURE
- 6.5.2. SEGMENT ANALYSIS
6.6. NEUROLOGICAL DISORDERS
- 6.6.1. MARKET FORECAST FIGURE
- 6.6.2. SEGMENT ANALYSIS
6.7. PAIN MANAGEMENT
- 6.7.1. MARKET FORECAST FIGURE
- 6.7.2. SEGMENT ANALYSIS
6.8. RESPIRATORY DISEASES
- 6.8.1. MARKET FORECAST FIGURE
- 6.8.2. SEGMENT ANALYSIS
6.9. OTHER THERAPY AREAS
- 6.9.1. MARKET FORECAST FIGURE
- 6.9.2. SEGMENT ANALYSIS

7. MARKET BY TYPE

7.1. NON-COLD CHAIN LOGISTICS
- 7.1.1. MARKET FORECAST FIGURE
- 7.1.2. SEGMENT ANALYSIS
7.2. COLD CHAIN LOGISTICS
- 7.2.1. MARKET FORECAST FIGURE
- 7.2.2. SEGMENT ANALYSIS

8. MARKET BY COMPONENT

8.1. STORAGE
- 8.1.1. WAREHOUSE
  - 8.1.1.1. MARKET FORECAST FIGURE
  - 8.1.1.2. SEGMENT ANALYSIS
- 8.1.2. REFRIGERATED CONTAINERS
  - 8.1.2.1. MARKET FORECAST FIGURE
  - 8.1.2.2. SEGMENT ANALYSIS
8.2. TRANSPORTATION
- 8.2.1. OVERLAND LOGISTICS
  - 8.2.1.1. MARKET FORECAST FIGURE
  - 8.2.1.2. SEGMENT ANALYSIS
- 8.2.2. SEA FREIGHT LOGISTICS
  - 8.2.2.1. MARKET FORECAST FIGURE
  - 8.2.2.2. SEGMENT ANALYSIS
- 8.2.3. AIR FREIGHT LOGISTICS
  - 8.2.3.1. MARKET FORECAST FIGURE
  - 8.2.3.2. SEGMENT ANALYSIS
8.3. MONITORING COMPONENTS
- 8.3.1. HARDWARE
  - 8.3.1.1. SENSORS
  - 8.3.1.1.1. MARKET FORECAST FIGURE
  - 8.3.1.1.2. SEGMENT ANALYSIS
  - 8.3.1.2. RFID DEVICES
  - 8.3.1.2.1. MARKET FORECAST FIGURE
  - 8.3.1.2.2. SEGMENT ANALYSIS
  - 8.3.1.3. TELEMATICS
  - 8.3.1.3.1. MARKET FORECAST FIGURE
  - 8.3.1.3.2. SEGMENT ANALYSIS
  - 8.3.1.4. NETWORKING DEVICES
  - 8.3.1.4.1. MARKET FORECAST FIGURE
  - 8.3.1.4.2. SEGMENT ANALYSIS
- 8.3.2. SOFTWARE
  - 8.3.2.1. MARKET FORECAST FIGURE
  - 8.3.2.2. SEGMENT ANALYSIS

9. COMPETITIVE LANDSCAPE

9.1. KEY STRATEGIC DEVELOPMENTS
- 9.1.1. MERGERS & ACQUISITIONS
- 9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
- 9.1.3. PARTNERSHIPS & AGREEMENTS
- 9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
- 9.2.1. AGILITY LOGISTICS
  - 9.2.1.1. COMPANY OVERVIEW
  - 9.2.1.2. PRODUCT PORTFOLIO
  - 9.2.1.3. STRENGTHS & CHALLENGES
- 9.2.2. AP MOLLER - MAERSK
  - 9.2.2.1. COMPANY OVERVIEW
  - 9.2.2.2. PRODUCT PORTFOLIO
  - 9.2.2.3. STRENGTHS & CHALLENGES
- 9.2.3. CARDINAL HEALTH
  - 9.2.3.1. COMPANY OVERVIEW
  - 9.2.3.2. PRODUCT PORTFOLIO
  - 9.2.3.3. STRENGTHS & CHALLENGES
- 9.2.4. CENCORA (AMERISOURCEBERGEN)
  - 9.2.4.1. COMPANY OVERVIEW
  - 9.2.4.2. PRODUCT PORTFOLIO
  - 9.2.4.3. STRENGTHS & CHALLENGES
- 9.2.5. CEVA LOGISTICS
  - 9.2.5.1. COMPANY OVERVIEW
  - 9.2.5.2. PRODUCT PORTFOLIO
  - 9.2.5.3. STRENGTHS & CHALLENGES
- 9.2.6. DB SCHENKER
  - 9.2.6.1. COMPANY OVERVIEW
  - 9.2.6.2. PRODUCT PORTFOLIO
  - 9.2.6.3. STRENGTHS & CHALLENGES
- 9.2.7. DEUTSCHE POST AG
  - 9.2.7.1. COMPANY OVERVIEW
  - 9.2.7.2. PRODUCT PORTFOLIO
  - 9.2.7.3. STRENGTHS & CHALLENGES
- 9.2.8. DSV
  - 9.2.8.1. COMPANY OVERVIEW
  - 9.2.8.2. PRODUCT PORTFOLIO
  - 9.2.8.3. STRENGTHS & CHALLENGES
- 9.2.9. FEDEX
  - 9.2.9.1. COMPANY OVERVIEW
  - 9.2.9.2. PRODUCT PORTFOLIO
  - 9.2.9.3. STRENGTHS & CHALLENGES
- 9.2.10. KUEHNE + NAGEL
  - 9.2.10.1. COMPANY OVERVIEW
  - 9.2.10.2. PRODUCT PORTFOLIO
  - 9.2.10.3. STRENGTHS & CHALLENGES

Product Code: 85204

LIST OF TABLES

TABLE 1: MARKET SNAPSHOT - PHARMACEUTICAL LOGISTICS
TABLE 2: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY PRODUCT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY THERAPY AREA, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY COMPONENT, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: INDIA STORAGE MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: INDIA STORAGE MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: INDIA TRANSPORTATION MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 13: INDIA TRANSPORTATION MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 14: INDIA MONITORING COMPONENTS MARKET, BY SERVICE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 15: INDIA MONITORING COMPONENTS MARKET, BY SERVICE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 16: INDIA HARDWARE MARKET, BY HARDWARE TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 17: INDIA HARDWARE MARKET, BY HARDWARE TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 18: LIST OF MERGERS & ACQUISITIONS
TABLE 19: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 20: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 21: LIST OF BUSINESS EXPANSIONS & DIVESTITURES

LIST OF FIGURES

FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR INDIA
FIGURE 4: MARKET CONCENTRATION ANALYSIS
FIGURE 5: VALUE CHAIN ANALYSIS
FIGURE 6: KEY BUYING CRITERIA
FIGURE 7: INDIA PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2023
FIGURE 8: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY BRANDED DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 9: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY GENERIC DRUGS, 2024-2032 (IN $ MILLION)
FIGURE 10: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY OTC, 2024-2032 (IN $ MILLION)
FIGURE 11: INDIA PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY THERAPY AREA, IN 2023
FIGURE 12: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY COMMUNICABLE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 13: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY ONCOLOGY, 2024-2032 (IN $ MILLION)
FIGURE 14: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY DIABETES, 2024-2032 (IN $ MILLION)
FIGURE 15: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY CARDIOVASCULAR DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 16: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY AUTOIMMUNE DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 17: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY NEUROLOGICAL DISORDERS, 2024-2032 (IN $ MILLION)
FIGURE 18: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY PAIN MANAGEMENT, 2024-2032 (IN $ MILLION)
FIGURE 19: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY RESPIRATORY DISEASES, 2024-2032 (IN $ MILLION)
FIGURE 20: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY OTHER THERAPY AREAS, 2024-2032 (IN $ MILLION)
FIGURE 21: INDIA PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 22: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY NON-COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 23: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY COLD CHAIN LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 24: INDIA PHARMACEUTICAL LOGISTICS MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2023
FIGURE 25: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY STORAGE, 2024-2032 (IN $ MILLION)
FIGURE 26: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY WAREHOUSE, 2024-2032 (IN $ MILLION)
FIGURE 27: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY REFRIGERATED CONTAINERS, 2024-2032 (IN $ MILLION)
FIGURE 28: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY TRANSPORTATION, 2024-2032 (IN $ MILLION)
FIGURE 29: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY OVERLAND LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 30: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY SEA FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 31: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY AIR FREIGHT LOGISTICS, 2024-2032 (IN $ MILLION)
FIGURE 32: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY MONITORING COMPONENTS, 2024-2032 (IN $ MILLION)
FIGURE 33: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY HARDWARE, 2024-2032 (IN $ MILLION)
FIGURE 34: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY SENSORS, 2024-2032 (IN $ MILLION)
FIGURE 35: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY RFID DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 36: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY TELEMATICS, 2024-2032 (IN $ MILLION)
FIGURE 37: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY NETWORKING DEVICES, 2024-2032 (IN $ MILLION)
FIGURE 38: INDIA PHARMACEUTICAL LOGISTICS MARKET, BY SOFTWARE, 2024-2032 (IN $ MILLION)